ROCKWELL MEDICAL, INC. Finance Lease, Principal Payments
ROCKWELL MEDICAL, INC. (RMTI) reported Finance Lease, Principal Payments of $117.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. finance lease, principal payments for the quarter ending 2026-06-30 was $117.00K, a 20.95% decline year-over-year.
- ROCKWELL MEDICAL, INC. finance lease, principal payments for the quarter ending 2026-03-31 was $115.00K, a 21.23% decline year-over-year.
- ROCKWELL MEDICAL, INC. finance lease, principal payments for the quarter ending 2025-12-31 was $111.00K, a 21.83% decline year-over-year.
- ROCKWELL MEDICAL, INC. finance lease, principal payments for the quarter ending 2025-09-30 was $124.00K, a 11.43% decline year-over-year.
- ROCKWELL MEDICAL, INC. finance lease, principal payments for fiscal 2025 was $529.00K, a 5.20% decline from fiscal 2024.
- ROCKWELL MEDICAL, INC. finance lease, principal payments for fiscal 2024 was $558.00K, a 6.90% increase from fiscal 2023.
- ROCKWELL MEDICAL, INC. finance lease, principal payments for fiscal 2023 was $522.00K, a 8.30% increase from fiscal 2022.
- ROCKWELL MEDICAL, INC. finance lease, principal payments for fiscal 2022 was $482.00K, a 89.02% increase from fiscal 2021.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 3 month as first filed | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 6 month as first filed | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 9 month as first filed | Finance Lease, Principal Payments 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $117.00K 10-Q · filed 2026-08-13 | $232.00K 10-Q · filed 2026-08-13 | $343.00K derived: sum of 3 quarters · filed 2026-08-13 | $467.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $115.00K 10-Q · filed 2026-05-07 | $226.00K derived: sum of 2 quarters · filed 2026-05-07 | $350.00K derived: sum of 3 quarters · filed 2026-05-07 | $498.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | $111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $235.00K derived: sum of 2 quarters · filed 2026-03-26 | $383.00K derived: sum of 3 quarters · filed 2026-08-13 | $529.00K 10-K · filed 2026-03-26 | |||
| 2025-09-30 | $124.00K 10-Q · filed 2025-11-12 | $272.00K derived: sum of 2 quarters · filed 2026-08-13 | $418.00K 10-Q · filed 2025-11-12 | $560.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $148.00K 10-Q · filed 2026-08-13 | $294.00K 10-Q · filed 2026-08-13 | $436.00K derived: sum of 3 quarters · filed 2026-08-13 | $576.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $146.00K 10-Q · filed 2026-05-07 | $288.00K derived: sum of 2 quarters · filed 2026-05-07 | $428.00K derived: sum of 3 quarters · filed 2026-05-07 | $566.00K derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $142.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $282.00K derived: sum of 2 quarters · filed 2026-03-26 | $420.00K derived: sum of 3 quarters · filed 2026-03-26 | $558.00K 10-K · filed 2026-03-26 | |||
| 2024-09-30 | $140.00K 10-Q · filed 2025-11-12 | $278.00K derived: sum of 2 quarters · filed 2025-11-12 | $416.00K 10-Q · filed 2025-11-12 | $550.00K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $138.00K 10-Q · filed 2025-08-14 | $276.00K 10-Q · filed 2025-08-14 | $410.00K derived: sum of 3 quarters · filed 2025-08-14 | $540.00K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $138.00K 10-Q · filed 2025-05-12 | $272.00K derived: sum of 2 quarters · filed 2025-05-12 | $402.00K derived: sum of 3 quarters · filed 2025-05-12 | $532.00K derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $264.00K derived: sum of 2 quarters · filed 2025-03-20 | $394.00K derived: sum of 3 quarters · filed 2025-03-20 | $522.00K 10-K · filed 2025-03-20 | |||
| 2023-09-30 | $130.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $260.00K derived: sum of 2 quarters · filed 2024-11-12 | $388.00K 10-Q · filed 2024-11-12 | $870.00K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $258.00K 10-Q · filed 2024-08-08 | $740.00K derived: sum of 3 quarters · filed 2024-08-08 | $861.00K derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $128.00K 10-Q · filed 2024-05-14 | $610.00K derived: sum of 2 quarters · filed 2024-05-14 | $731.00K derived: sum of 3 quarters · filed 2024-05-14 | $850.00K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $482.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $603.00K derived: sum of 2 quarters · filed 2024-03-21 | $722.00K derived: sum of 3 quarters · filed 2024-03-21 | $482.00K 10-K · filed 2024-03-21 | |||
| 2022-09-30 | $121.00K 10-Q · filed 2022-11-14 | $240.00K derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2023-11-14 | $359.00K 10-Q · filed 2022-11-14 | $343.00K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2022-06-30 | $119.00K 10-Q · filed 2022-08-15 | $0.00 10-Q · filed 2023-08-14 | $237.00K 10-Q · filed 2022-08-15 | $222.00K derived: sum of 3 quarters · filed 2023-05-15 | $281.00K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | $118.00K 10-Q · filed 2022-05-16 | $103.00K derived: sum of 2 quarters · filed 2023-05-15 | $162.00K derived: sum of 3 quarters · filed 2023-05-15 | $218.00K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $162.00K derived: sum of 2 quarters · filed 2023-03-30 | $218.00K derived: sum of 3 quarters · filed 2023-03-30 | $255.00K 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $59.00K 10-Q · filed 2022-11-14 | $115.00K derived: sum of 2 quarters · filed 2022-11-14 | $152.00K 10-Q · filed 2022-11-14 | $169.00K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $56.00K 10-Q · filed 2022-08-15 | $93.00K 10-Q · filed 2022-08-15 | $110.00K derived: sum of 3 quarters · filed 2022-08-15 | $110.00K derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $37.00K 10-Q · filed 2022-05-16 | $54.00K derived: sum of 2 quarters · filed 2022-05-16 | $54.00K derived: sum of 3 quarters · filed 2022-05-16 | $54.00K derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $17.00K derived: sum of 2 quarters · filed 2022-04-08 | $17.00K derived: sum of 3 quarters · filed 2022-04-08 | $17.00K 10-K · filed 2022-04-08 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | |||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 | ||||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |